Teppei Sakamoto

833 total citations
34 papers, 466 citations indexed

About

Teppei Sakamoto is a scholar working on Cancer Research, Molecular Biology and Hepatology. According to data from OpenAlex, Teppei Sakamoto has authored 34 papers receiving a total of 466 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Cancer Research, 11 papers in Molecular Biology and 11 papers in Hepatology. Recurrent topics in Teppei Sakamoto's work include MicroRNA in disease regulation (7 papers), Hepatitis C virus research (7 papers) and Circular RNAs in diseases (6 papers). Teppei Sakamoto is often cited by papers focused on MicroRNA in disease regulation (7 papers), Hepatitis C virus research (7 papers) and Circular RNAs in diseases (6 papers). Teppei Sakamoto collaborates with scholars based in Japan, Somalia and United States. Teppei Sakamoto's co-authors include Tsutomu Masaki, Asahiro Morishita, Takako Nomura, Hirohito Yoneyama, Joji Tani, Koji Fujita, Hisakazu Iwama, Tomoko Tadokoro, Takashi Himoto and Kyoko Oura and has published in prestigious journals such as International Journal of Molecular Sciences, World Journal of Gastroenterology and Oncotarget.

In The Last Decade

Teppei Sakamoto

33 papers receiving 460 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Teppei Sakamoto Japan 12 204 124 120 118 109 34 466
Tixiao Wang China 12 290 1.4× 128 1.0× 257 2.1× 123 1.0× 120 1.1× 18 654
Timo Itzel Germany 13 232 1.1× 110 0.9× 74 0.6× 235 2.0× 123 1.1× 29 603
F. Mihaimeed United Kingdom 5 332 1.6× 105 0.8× 118 1.0× 53 0.4× 91 0.8× 6 529
Pei Kee Goh Australia 6 285 1.4× 77 0.6× 182 1.5× 195 1.7× 147 1.3× 8 564
Chengyu Shi China 15 386 1.9× 215 1.7× 104 0.9× 148 1.3× 119 1.1× 26 659
Guohe Song China 10 216 1.1× 142 1.1× 50 0.4× 113 1.0× 131 1.2× 19 471
Brian Bridges United States 7 193 0.9× 49 0.4× 74 0.6× 123 1.0× 65 0.6× 8 389
Yutaka Yamanaka Japan 14 334 1.6× 159 1.3× 72 0.6× 111 0.9× 113 1.0× 27 539
Catia Lippolis Italy 13 165 0.8× 128 1.0× 41 0.3× 62 0.5× 138 1.3× 19 476
Caihong Liang China 12 292 1.4× 200 1.6× 119 1.0× 62 0.5× 48 0.4× 16 500

Countries citing papers authored by Teppei Sakamoto

Since Specialization
Citations

This map shows the geographic impact of Teppei Sakamoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Teppei Sakamoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Teppei Sakamoto more than expected).

Fields of papers citing papers by Teppei Sakamoto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Teppei Sakamoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Teppei Sakamoto. The network helps show where Teppei Sakamoto may publish in the future.

Co-authorship network of co-authors of Teppei Sakamoto

This figure shows the co-authorship network connecting the top 25 collaborators of Teppei Sakamoto. A scholar is included among the top collaborators of Teppei Sakamoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Teppei Sakamoto. Teppei Sakamoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Nomura, Takako, Asahiro Morishita, Joji Tani, et al.. (2020). A case report of granulocyte colony-stimulating factor-producing hepatocellular carcinoma that recurred after long-term complete response. Clinical Journal of Gastroenterology. 14(1). 204–211. 4 indexed citations
3.
Oura, Kyoko, Koji Fujita, Asahiro Morishita, et al.. (2019). Serum microRNA‑125a‑5p as a potential biomarker of HCV‑associated hepatocellular carcinoma. Oncology Letters. 18(1). 882–890. 20 indexed citations
4.
Tadokoro, Tomoko, Asahiro Morishita, Teppei Sakamoto, et al.. (2017). Galectin-9 ameliorates fulminant liver injury. Molecular Medicine Reports. 16(1). 36–42. 10 indexed citations
5.
Oura, Kyoko, Tomoko Tadokoro, Shintaro Fujihara, et al.. (2017). Telmisartan inhibits hepatocellular carcinoma cell proliferation in vitro by inducing cell cycle arrest. Oncology Reports. 38(5). 2825–2835. 43 indexed citations
6.
Fujita, Koji, Toshiro Niki, Takako Nomura, et al.. (2017). Correlation between serum galectin‐9 levels and liver fibrosis. Journal of Gastroenterology and Hepatology. 33(2). 492–499. 23 indexed citations
7.
Morishita, Asahiro, Hisakazu Iwama, Shintaro Fujihara, et al.. (2017). Targeted sequencing of cancer‑associated genes in hepatocellular carcinoma using next‑generation sequencing. Oncology Letters. 15(1). 528–532. 9 indexed citations
8.
Morishita, Asahiro, Hisakazu Iwama, Shintaro Fujihara, et al.. (2016). MicroRNA profiles in various hepatocellular carcinoma cell lines. Oncology Letters. 12(3). 1687–1692. 21 indexed citations
9.
Morishita, Asahiro, Hirohito Yoneyama, Takako Nomura, et al.. (2016). Primary hepatic neuroendocrine tumor: A case report. Molecular and Clinical Oncology. 4(6). 954–956. 17 indexed citations
10.
Sakamoto, Teppei, Asahiro Morishita, Takako Nomura, et al.. (2016). Identification of microRNA profiles associated with refractory primary biliary cirrhosis. Molecular Medicine Reports. 14(4). 3350–3356. 26 indexed citations
11.
Fujita, Koji, Hisakazu Iwama, Hisaaki Miyoshi, et al.. (2016). Diabetes mellitus and metformin in hepatocellular carcinoma. World Journal of Gastroenterology. 22(27). 6100–6100. 55 indexed citations
12.
Tadokoro, Tomoko, Asahiro Morishita, Shintaro Fujihara, et al.. (2016). Galectin-9: An anticancer molecule for gallbladder carcinoma. International Journal of Oncology. 48(3). 1165–1174. 25 indexed citations
13.
Fujita, Koji, Hisakazu Iwama, Kyoko Oura, et al.. (2016). Metformin-suppressed differentiation of human visceral preadipocytes: Involvement of microRNAs. International Journal of Molecular Medicine. 38(4). 1135–1140. 18 indexed citations
14.
Morishita, Asahiro, Teppei Sakamoto, Hideki Kobara, et al.. (2015). Evaluation of in vivo efficacy of radiofrequency ablation with D-sorbitol in animal liver. Molecular and Clinical Oncology. 4(2). 183–186. 2 indexed citations
15.
Morishita, Asahiro, Teppei Sakamoto, Kiyohito Kato, et al.. (2015). MicroRNA profiles in cisplatin-induced apoptosis of hepatocellular carcinoma cells. International Journal of Oncology. 47(2). 535–542. 10 indexed citations
16.
Morishita, Asahiro, Hirohito Mori, Hideki Kobara, et al.. (2015). Successful mucosal incision-assisted biopsy for the histological diagnosis of duodenal lymphoma: A case report. Oncology Letters. 11(1). 531–534. 1 indexed citations
17.
Mimura, Shima, Hisakazu Iwama, Kiyohito Kato, et al.. (2014). Profile of microRNAs associated with aging in rat liver. International Journal of Molecular Medicine. 34(4). 1065–1072. 29 indexed citations
18.
Watanabe, Seishiro, Asahiro Morishita, Akihiro Deguchi, et al.. (2014). Ethanol injection therapy for small hepatocellular carcinomas located beneath a large vessel using a curved percutaneous ethanol injection therapy needle. Oncology Letters. 7(6). 1831–1834. 3 indexed citations
19.
Miyoshi, Hisaaki, Asahiro Morishita, Joji Tani, et al.. (2013). Expression profiles of 507 proteins from a biotin label-based antibody array in human colorectal cancer. Oncology Reports. 31(3). 1277–1281. 11 indexed citations
20.
Nomura, Takako, Asahiro Morishita, Shima Mimura, et al.. (2013). Expression of angiogenic factors in hepatocarcinogenesis: Identification by antibody arrays. Oncology Reports. 30(5). 2476–2480. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026